International Cancer Imaging Society

International Cancer Imaging Society Meeting and 16th Annual Teaching Course

Cancer Imaging: More Than Meets the Eye

Mon 03 Oct 2016 - Wed 05 Oct 2016

Technology & Innovation Centre (TIC), Glasgow, Scotland, UK

» Meeting details  

» Register here  

» Submit an Abstract  

Interactive Workshops

Masterclass in Imaging of Prostate Cancer

Mon 24 Oct 2016  Stockholm, Sweden 

» Registration Open 

Masterclass in Imaging of Pancreatic Tumours

Thu 3 Nov 2016  London, UK 

» Registration Open  

Cancer Imaging Journal

Cancer Imaging is the official journal of ICIS, it is an open access, peer-reviewed journal with original articles as well as reviews and editorials.  The journal encompasses CT, MRI, ultrasound, single photon and positron emission tomography, including multimodality imaging in all kinds of malignant tumours, plus new developments, techniques and innovations.

About ICIS

The International Cancer Imaging Society exists to meet the important challenges of advancing imaging in the multidisciplinary management of cancer.

We promote education in oncological imaging and stimulate research in the study of human tumour behaviour, bringing together radiologists with an interest in oncological imaging for the exchange of ideas, and to organise scientific meetings, multicentre research studies and postgraduate courses within the field.

 

» President's Message 

» Latest News 

Join our Society

Do you believe that Cancer Imaging is important?

If your answer is yes, join us to support and promote the education in oncological imaging and stimulate research in the study of human tumour behaviour.

As a member you will also receive:

  • Discounted registration fees for all our teaching courses
  • Exclusive access to the members' area
  • Exclusive access to posters and presentations from the annual teaching course
  • 15% off the APC for submitting manuscripts to Cancer Imaging

» Join now 

How I Read Cancer Imaging Studies: The Master Class Series
12 April 2016

How I Read Cancer Imaging Studies: The Master Class Series

Join us for an online discussion in the members’ forum

In contrast to the literature regarding the outcomes of imaging, the methods that underpin the generation of a report and how to communicate the findings cogently to referring clinicians, remains something of a “black box”. In an insightful thematic series of articles that recently published in Cancer Imaging, experts in various modalities detail their approach to reporting scans in particular disease settings. 

In his introductory editorial, Prof. Rodney Hicks details the motivation for his "Master Class Series" and his own approach to reporting. This is a unique opportunity to break into data traditionally locked into the brains of experts and only intermittently shared with their own direct trainees, or alternatively, at often expensive masterclass presentations.

» Read more

As a Radiologist who focuses on Cancer Imaging, I find ICIS courses and meetings extremely useful and stimulating. Not only do I get to meet the doyens in the field, the courses and meetings are so rich in state of art technology and new developments in the field of cancer imaging. There is no other imaging conference, that gives me so much value for the time.

BP | Australia

Register your interest for all ICIS interactive courses

Please click on the link below to register your interest for future ICIS interactive courses.  We will notify you in advance of registration opening, allowing you first refusal on this popular range of courses.

To register your interest, fill in the details below and click on the "Register Interest" button.






Subscribe to our mailing list

* indicates required
Email Format

Cancer / Oncology News From Medical News Today

Simple test predicts childhood cancer relapse

Published: Thu, 05 May 2016 17:00:00 GMT

A cheap simple test could accurately predict the recurrence of a childhood cancer.

European Commission approves Halaven (eribulin) for treatment of advanced liposarcoma in Europe

Published: Thu, 05 May 2016 13:00:00 GMT

Eribulin is the first and only single agent to show a significant improvement in overall survival for people with advanced liposarcomas.

Antiviral therapies give hepatitis C cirrhosis patients similar life expectancy as general population

Published: Thu, 05 May 2016 12:00:00 GMT

The survival rate of patients with hepatitis C virus-related cirrhosis who respond well to antiviral therapies equals that of the general population, say investigators in the Journal of Hepatology.

Discovery of cancer gene may predict survival in patients with mouth cancers

Published: Thu, 05 May 2016 11:00:00 GMT

Loyola researchers have identified a tumor gene that may help to predict survival outcomes in patients with cancer of the mouth and tongue.If the gene is expressed (turned on), patients are 4.

TSRI scientists find root cause of appetite loss during illness

Published: Thu, 05 May 2016 10:00:00 GMT

The discovery opens the door to new therapies influencing appetite and weight.

Teledermatology linked to access to dermatologists for Medicaid enrollees in California

Published: Wed, 04 May 2016 15:00:00 GMT

Primary care practices in a large California Medicaid managed care plan offering teledermatology had an increased fraction of patients who visited a dermatologist compared with other practices...

Scientists create tasty ginger beverages with healthy qualities

Published: Wed, 04 May 2016 13:00:00 GMT

One is a soft drink and the other is milk fermented, both help the intestinal system, and their antioxidant activity may contribute to the prevention of cancer and vascular diseases.

AUA, SUO release new clinical practice guideline on the diagnosis and treatment of non-muscle invasive bladder cancer

Published: Wed, 04 May 2016 11:00:00 GMT

The American Urological Association (AUA), together with the Society for Urologic Oncology (SUO), today released a new clinical practice guideline on non-muscle invasive bladder cancer (NMIBC).

Autism and cancer share a remarkable number of risk genes in common

Published: Wed, 04 May 2016 08:00:00 GMT

Autism and cancer share more than 40 risk genes, suggesting that common mechanisms underlying the functions of some of these genes could conceivably be leveraged to develop therapies not just for...

Herbal remedies are an overlooked global health hazard

Published: Wed, 04 May 2016 08:00:00 GMT

Millions of people around the world use herbal health remedies, following a tradition that began millennia ago.

Largest study of patients with early stage II testicular cancer shows radiation therapy is more effective than chemotherapy

Published: Tue, 03 May 2016 16:00:00 GMT

A large study of testicular cancer patients has shown that radiation therapy is a better treatment than chemotherapy for patients with stage IIa disease (where one or more regional lymph nodes...

Personalized breast cancer treatment steps closer with gene discovery

Published: Tue, 03 May 2016 15:00:00 GMT

Researchers have shed light on which gene mutations and mutational signatures drive breast cancer development, bringing us closer to personalized treatment for the disease.

Prostate cancer: new drugs show promise against aggressive, resistant forms

Published: Tue, 03 May 2016 14:00:00 GMT

Tests in mice show that new drugs called Hsp90 inhibitors can disable a mechanism in prostate cancer cells that allows them to evade standard treatment.

Elevated bladder cancer risk in New England and arsenic in drinking water from private wells

Published: Tue, 03 May 2016 14:00:00 GMT

A new study has found that drinking water from private wells, particularly dug wells established during the first half of the 20th century, may have contributed to the elevated risk of bladder...

New European policy recommendations on cytotoxic drugs

Published: Tue, 03 May 2016 12:00:00 GMT

New policy recommendations on preventing occupational exposure to cytotoxic drugs were launched in the European Parliament on 26 April 2016, an important new initiative designed to protect...

New drug-delivery approach holds potential for treating obesity

Published: Tue, 03 May 2016 11:00:00 GMT

Researchers at MIT and Brigham and Women's Hospital have developed nanoparticles that can deliver antiobesity drugs directly to fat tissue.

HPV infection can be identified in self-collected vaginal swabs

Published: Tue, 03 May 2016 07:00:00 GMT

High risk, potentially cancer causing human papillomavirus infections are common among women in Papua New Guinea.

Bile duct cancer risk may be reduced with aspirin use

Published: Mon, 02 May 2016 15:00:00 GMT

The risk of bile duct cancer, or cholangiocarcinoma, was reduced by up to 3.6-fold for aspirin users in a new study, providing further evidence of the drug's anticancer effects.

Cognitive-behavioral therapy may help reduce memory problems in cancer survivors who have received chemotherapy

Published: Mon, 02 May 2016 05:00:00 GMT

A new analysis indicates that a type of psychotherapy delivered by videoconference may help prevent some of the long-term memory issues caused by chemotherapy.

Radiation and immunotherapy combination can destroy both primary and secondary tumours

Published: Sat, 30 Apr 2016 22:00:00 GMT

Radiation therapy not only kills cancer cells, but also helps to activate the immune system against their future proliferation.